What MEDISYN SA does

MEDISYN SA is a Swiss medical laboratory company headquartered in Kriens, canton of Lucerne, providing the full spectrum of routine and specialised laboratory medicine across German-, French-, and Italian-speaking Switzerland. The company employs approximately 600 people and operates more than 40 laboratory locations and over 25 blood collection centres, organised around three regional competence centres in Luzern, Lausanne, and Bioggio that handle complex specialised analyses. It offers more than 5,000 diagnostic tests spanning clinical chemistry, haematology, microbiology, immunology, infectious serology, genetics, oncology, pathology, nephrology, and clinical pharmacology, with niche offerings including the ROCA® ovarian cancer risk algorithm, Prendia non-invasive prenatal testing, myPGx pharmacogenetics, a 27-gene oncology panel, and liquid biopsy for circulating tumour DNA/RNA.

The underlying technology platform is sylex®, a proprietary digital health solution that enables 24/7 electronic laboratory order entry and validated result retrieval directly from practice or clinic software, with the sylex® Box hardware device for point-of-care testing (POCT) device integration and mobile apps for Android and iPhone. Sample logistics are handled by MEDISYN's own courier service covering the whole of Switzerland with continuous cold chain, and main sites carry DIN EN ISO 17025 accreditation with Medisyn Ticino additionally accredited to SN EN ISO/IEC 15189:2022 (SMTS 0120) under Swiss Accreditation Service monitoring.

MEDISYN operates a B2B sales-led go-to-market targeting general practitioners, specialist physicians, and hospital customers, complemented by wholly-owned subsidiaries including one-provide ag (e-commerce for medical supplies and POCT devices) and Institut Arnaboldi (pathology in Winterthur). The company is part of the Sonic Suisse / SYNLAB Suisse network within Sonic Healthcare. Revenue is generated through diagnostic testing services billed to healthcare providers and patients, supply sales via one-provide ag, and platform subscriptions via sylex®, with COVID-19 RT-PCR, serology, and antigen testing as an additional transactional revenue stream during the pandemic. Marketing is built around medical education — scientific publications (SYNFO), webinars, MPA continuing education, and congress participation — rather than consumer advertising.

Name

MEDISYN SA

Legal name

MEDISYN SA

Website

https://medisyn.ch

Company type

Private

Operating status

Operating

Headcount range

501–1,000 employees

Short description

MEDISYN SA is a Swiss medical laboratory company operating ~40 laboratory locations and 25+ collection centres across German-, French-, and Italian-speaking Switzerland, offering 5,000+ diagnostic tests and the proprietary sylex® digital platform to GPs, specialists, and hospitals. It is part of the SYNLAB Suisse / Sonic Healthcare network.

Ownership category

akta.pro rank

Product category

Medical Laboratory Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

Keywords

• Medical laboratory diagnostics
• Clinical pathology services
• Human genetics testing
• Pharmacogenetics analysis
• Laboratory information systems

Headquarters

HQ city

Kriens

HQ country

Switzerland

HQ region

Europe

Offices18 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Laboratory Diagnostic Testing Services: MEDISYN SA provides the full spectrum of routine and specialized laboratory medicine including anatomical pathology and human genetics. Revenue is generated through diagnostic testing services billed to healthcare providers, hospitals, clinics, and patients. The company offers more than 5,000 diagnostic tests. Regional competence centres handle complex analyses, and routine testing is distributed across a network of local laboratories.
2. sylex® Digital Health Platform: The sylex® platform provides an intelligent, simple, and secure digital solution for information exchange between healthcare participants and MEDISYN laboratories. The platform enables rapid and secure order entry and result retrieval from practice or clinic software, available 24/7 with real-time updates.
3. Medical Supplies (via one-provide ag): one-provide ag, a member company of MEDISYN SA, supplies medical analysis equipment, consumables, reagents, point-of-care testing devices, practice supplies, and medical equipment to modern medical practices under an 'All from one source for your practice' concept.
4. COVID-19 Testing Services: MEDISYN SA offered COVID-19 RT-PCR testing, serological testing, and antigen testing at collection centres across Switzerland.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

MEDISYN SA is a Swiss medical laboratory company providing routine and specialized laboratory medicine diagnostics, including anatomical pathology and human genetics. The company serves general practitioners, specialists, and hospital customers across Switzerland through a network of more than 40 laboratory locations and 25+ blood collection centres, supported by a proprietary digital platform (sylex®) for 24/7 electronic order entry and result retrieval, and its own courier service for sample transport.

Product overview

MEDISYN SA offers a comprehensive laboratory medicine portfolio encompassing over 5000 diagnostic tests. The core offering includes routine and specialized laboratory analyses spanning clinical chemistry, hematology/coagulation, microbiology, genetics, immunology, infectious serology, oncology, pathology, nephrology, and cardiology. Key service brands include sylex® (cloud-based LIS platform for 24/7 real-time electronic lab orders and result delivery), sylex® Box (POCT device integration hardware), and the one-provide ag online shop for medical supplies. Additional offerings include COVID-19 testing, ROCA® ovarian cancer risk assessment, Prendia non-invasive prenatal testing, myPGX pharmacogenetics, and liquid biopsy for oncology. The company also provides MPA continuing education and operates a network of over 25 collection centres across Switzerland.

Differentiator

Problem solved

Functional benefit

Brands

• sylex: Digital health solution for secure information exchange between healthcare participants and MEDISYN laboratory, including 24/7 lab ordering and results access.
• MEDISYN Pathology
• one-provide ag
• MyMediService

Products and services

• sylex® Digital Health Platform Intelligent digital information exchange platform between all participants in the Swiss healthcare system and the MEDISYN laboratory, providing 24/7 real-time electronic order entry and validated result retrieval directly from practice or clinic software.
• Collection Centres Network Network of more than 25 blood collection centres across Switzerland offering patient access to blood sampling and laboratory analysis services across German-, French-, and Italian-speaking regions.
• ROCA® Ovarian Cancer Risk Test Risk of Ovarian Cancer Algorithm test for women with known pathogenic BRCA1/2 variants, combining CA-125 blood level changes with age and clinical factors to stratify ovarian cancer risk.
• Prendia Non-Invasive Prenatal Test (NIPT) Non-invasive prenatal screening test for detecting chromosomal abnormalities during pregnancy, offered as part of MEDISYN SA's pregnancy diagnostics services.
• myPGX Pharmacogenetics Service Pharmacogenetic testing service that analyses genes related to drug metabolism and transport to optimise drug efficacy and avoid adverse drug effects, with clinical-pharmacological consultation included.
• Liquid Biopsy Service (Flüssigbiopsie) Oncology service analysing circulating tumour DNA (ctDNA) and circulating tumour RNA (ctRNA) from blood or other body fluids for non-invasive tumour profiling.
• Oncology Panel (27-gene) Oncogenetic testing panel comprising 27 genes (10 commonly involved in breast cancer and 11 in ovarian cancer), formerly known as BRCAPlus™, used for hereditary cancer risk assessment.
• COVID-19 Testing Services COVID-19 diagnostic services including RT-PCR testing, serological antibody testing, and antigen rapid testing available at collection centres across Switzerland.
• Institut Arnaboldi Pathology Services Anatomical pathology services including histology, cytology, immunohistochemistry, and intraoperative rapid sections offered through Institut Arnaboldi, a MEDISYN SA member company in Winterthur.
• MPA Continuing Education Programme Continuing education programme for medical practice assistants (MPA) covering phlebotomy, preanalytics, quality control interpretation, LAP preparation, and sylex® platform training.
• Routine and Specialized Laboratory Medicine Comprehensive laboratory medicine services spanning routine and specialised analyses in clinical chemistry, haematology/coagulation, microbiology, immunology, infectious serology, genetics, oncology, nephrology, cardiology, and clinical pharmacology, with more than 5,000 diagnostic tests available.

Quantifiable outcome

• 60–70% of all medical diagnoses and decisions are supported by laboratory test results, while laboratory medicine accounts for only an estimated 2–3% of total healthcare costs.
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Sonic Suisse / SYNLAB SuissecoreOthersMEDISYN SA belongs to the Sonic Suisse network, described as one of the world's leading providers of medical diagnostic services. It is also part of the SYNLAB Suisse network. SYNLAB Suisse is a major European laboratory medicine group with operations across multiple countries. This affiliation provides MEDISYN SA with international expertise, shared resources, and brand association within the global diagnostics ecosystem.
• one-provide agcoreStrategic or Co-development Partnerone-provide ag is described as a member company of MEDISYN SA, operating under the concept 'All from one source for your practice.' It supplies medical analysis equipment, consumables, reagents, and POCT devices to modern medical practices across Switzerland. Located at Sternmatt 6, Kriens — the same address as MEDISYN SA headquarters. The company runs an e-commerce platform at one-provide.ch and is a key component of MEDISYN SA's broader service offering.
• Institut ArnaboldicoreStrategic or Co-development PartnerInstitut Arnaboldi is described as 'Ein Unternehmen von MEDISYN SA' (A company of MEDISYN SA). Located at Brunngasse 6, Winterthur, it specialises in pathology with services including histology, cytology, immunohistochemistry, and intraoperative rapid sections. It serves as a reference pathology centre for MEDISYN SA's network, offering microscopic examination of tissue and cell samples with a strong quality focus.
• Swisscom (Schweiz) Health AGminorChannel Partner/ Reseller/ DistributorA large proportion of patient invoices are processed directly by MEDISYN SA's billing partner Swisscom (Schweiz) Health AG. This partnership handles invoice management and processing on behalf of MEDISYN SA, streamlining the billing cycle for laboratory services.
• IRF (Stefan Mathys)minorOthersStefan Mathys of IRF (IRF Reputation) serves as the media contact for MEDISYN SA. All media enquiries are directed to him at IRF for handling. This is a communications/advisory relationship rather than a commercial partnership.
• LST Schenker AGminorOthersLST Schenker AG, located at Täschmattstrasse 19, 6015 Luzern, is credited as the designer of the MEDISYN SA website. This indicates a creative/design services relationship.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• SYNLAB: SYNLAB is a pan-European clinical laboratory leader and the operator behind SYNLAB Suisse; its broad geographic footprint, similar B2B model, and overlapping test menu make it a relevant strategic and operational peer to MEDISYN at group level.
• Unilabs: Unilabs is one of Europe's largest clinical laboratory operators with a presence in Switzerland, offering a comparable B2B diagnostics portfolio to hospitals and physicians, and competing head-to-head with MEDISYN's specialty and routine test menu.
• Roche Diagnostics: Roche Diagnostics is a global diagnostics leader headquartered in Switzerland; while primarily a manufacturer of diagnostics instruments and reagents rather than a direct lab operator, it is comparable in Swiss diagnostics footprint, R&D scale, and serves overlapping hospital and physician customers via its IVD platforms used by MEDISYN and peers.
• SYNLAB Suisse: SYNLAB Suisse is the broader Swiss laboratory network of which MEDISYN is a member brand. It operates multiple Swiss labs and offers a comparable spectrum of routine and specialty diagnostics, making it both MEDISYN's parent-affiliate and its closest direct competitor within Switzerland.
• Sonic Healthcare: Sonic Healthcare is MEDISYN's ultimate parent and one of the world's largest medical diagnostics groups; it operates analogous laboratory medicine businesses globally and is comparable in scope, scale, and service mix to MEDISYN at the consolidated level.
• Labcorp: Labcorp is a global clinical laboratory network offering a similar spectrum of routine and specialty diagnostics to physicians and hospitals; while not Swiss-based, its central-lab and specialty-test model, especially in oncology and genetics, is comparable to MEDISYN's higher-end specialty services.

Direct peers

• Dianalabs: Dianalabs is a Swiss medical laboratory that operates collection centres (including MEDISYN's Plainpalais Geneva site, accreditation SMTS 0023), providing routine and specialty diagnostics to physicians and patients on a comparable Swiss regional basis.
• Dr. Risch Gruppe: Dr. Risch is a Swiss medical laboratory group operating across multiple cantons with a similar mix of routine and specialty testing, hospital and physician customers, and pan-regional collection network, making it a close functional peer to MEDISYN.
• Viollier AG: Viollier is one of Switzerland's largest private medical laboratory groups, offering a comparable full menu of routine and specialised diagnostics with a similar national network and B2B focus on physicians and hospitals, putting it in direct competition with MEDISYN.

Others

• Institut Arnaboldi: Institut Arnaboldi is a pathology institute in Winterthur focused on histology, cytology, and immunohistochemistry; it is itself part of the MEDISYN group but is comparable as a specialty pathology reference lab competing with other Swiss histopathology providers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubevimeo.com/synlabsuisse
• LinkedInlinkedin.com/company/medisyn-sa

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MEDISYN SA